← Leaderboards
Charles Matthew Kerr
Medical University Of South Carolina
$126,153
Attributed
$126,153
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $46K · FY2020–22$50K$37.5K$25K$12.5K$0
'20
'21
'22
Funding mix
By agency
NIH$126,153 · 1
By mechanism
F31$126,153 · 1
Top collaborators
No co-investigators on record.
Most similar at Medical University Of South Carolina
Same institution · by research overlap
- Stephen A Duncan$28,157,111
- Mildred Christine Embree$7,107,285
- Roger R Markwald$12,840,778
- Arno Wessels$8,106,610
- Anand Ramamurthi$5,125,841
Others in their field
Other Emerging Leaders on “3-Dimensional”
- Karla Satchell · Northwestern University At Chicago$18,043,324
- Peter Myler · Seattle Children'S Hospital$17,499,932
- Hemali Phatnani · New York University School Of Medicine$12,981,994
- Stephen Wilson · La Jolla Institute For Immunology$11,742,477
- Tomasz Nowakowski · University Of California, San Francisco$11,499,053
- Siyuan Wang · Yale University$10,233,056
Research focus
3-DimensionalAdrenergic AgentsAdultAdipose TissueBiological ModelsCardiacCardiac MyocytesCardiovascular DiseasesAnimal ModelCellsChronicCoronary FibrosisCytokineDepositionDiagnosisDiffusionDisease ModelDrug TestingEffectivenessCause Of DeathEndocardiumEndothelial CellsEpicardiumExtracellular Matrix
Grant awards (3)
Improving cardiovascular disease modeling using human pluripotent stem cell-derived cardiac fibroblasts$34,597
F31 · FY2022 · HL · contact PI
Improving cardiovascular disease modeling using human pluripotent stem cell-derived cardiac fibroblasts$46,036
F31 · FY2021 · HL · contact PI
Improving cardiovascular disease modeling using human pluripotent stem cell-derived cardiac fibroblasts$45,520
F31 · FY2020 · HL · contact PI